Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Regulation of Hematopoiesis and Its Interaction with Stem Cell Niches
Authors
Fumio Arai
Atsushi Hirao
Toshio Suda
Publication date
01-12-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.05100

Other articles of this Issue 5/2005

International Journal of Hematology 5/2005 Go to the issue

Meeting Report

Paroxysmal Nocturnal Hemoglobinuria

Meeting Report

International Consensus Conference on Bone Marrow Failure Syndromes: Review and Recommendations

OriginalPaper

Low-dose Granulocyte Colony-Stimulating Factor Overcomes Neutropenia in the Treatment of Non-Hodgkin’s Lymphoma with Higher Cost-Effectiveness

Meeting Report

Aplastic Anemia

Case Report

Two Patients with All -trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent

OriginalPaper

Relationships between DNA Methylation and Expression in Erythrocyte Membrane Protein (Band 3, Protein 4.2, and β-Spectrin) Genes during Human Erythroid Development and Differentiation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits